Limoneira Co (LMNR) 16.62 $LMNR Limoneira to Announce

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 1:16 PM

Limoneira Co (LMNR) 16.62 $LMNR

Limoneira to Announce Third Quarter Fiscal Year 2016 Financial Results on September 8, 2016
BusinessWire - Fri Aug 26, 7:00AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced it will release financial results for the third quarter ended July 31, 2016, on Thursday, September 8, 2016, after the market close.
LMNR: 16.62 (+0.01)

Limoneira Provides Update on Positive 2016 Avocado Harvest
BusinessWire - Thu Aug 25, 7:30AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced an update on its recent avocado harvest and disposition of certain assets. In addition, the Company will report its financial results for the third quarter ended July 31, 2016 on Thursday, September 8, 2016.
LMNR: 16.62 (+0.01)

Limoneira Reiterates Fiscal Year 2016 Guidance Ranges
BusinessWire - Mon Aug 22, 3:05PM CDT
--- Company to Report Third Quarter Fiscal Year 2016 Results on September 8, 2016 -
LMNR: 16.62 (+0.01)

Limoneira Company Announces Second Quarter Fiscal Year 2016 Financial Results
BusinessWire - Thu Jun 09, 3:05PM CDT
---Company Reiterates Fiscal Year 2016 Guidance Ranges -
LMNR: 16.62 (+0.01)

Limoneira to Announce Second Quarter Fiscal Year 2016 Financial Results on June 9, 2016
BusinessWire - Thu May 26, 7:30AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced it will release financial results for the second quarter ended April 30, 2016, on Thursday, June 9, 2016, after the market close.
LMNR: 16.62 (+0.01)

Limoneira to Present at the 17th Annual B. Riley & Co. Annual Investor Conference
BusinessWire - Thu May 19, 7:30AM CDT
Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, today announced that Joe Rumley, the Company's Chief Financial Officer, will be presenting at the 17th Annual B. Riley & Co. Annual Investor Conference, to be held May 25-26, 2016, at The Loews Hollywood Hotel in Los Angeles, California.
LMNR: 16.62 (+0.01)

Limoneira Up 22.1% Since SmarTrend Uptrend Call (LMNR)
Comtex SmarTrend(R) - Wed May 11, 1:45PM CDT
SmarTrend identified an Uptrend for Limoneira (NASDAQ:LMNR) on February 26th, 2016 at $13.78. In approximately 3 months, Limoneira has returned 22.13% as of today's recent price of $16.83.
LMNR: 16.62 (+0.01)

23.9% Return Seen to Date on SmarTrend Limoneira Call (LMNR)
Comtex SmarTrend(R) - Wed May 04, 12:48AM CDT
SmarTrend identified an Uptrend for Limoneira (NASDAQ:LMNR) on February 26th, 2016 at $13.78. In approximately 2 months, Limoneira has returned 23.95% as of today's recent price of $17.08.
LMNR: 16.62 (+0.01)

Limoneira Wins American Planning Association Award for Comprehensive Plan
BusinessWire - Fri Apr 29, 7:30AM CDT
Limoneira Company (the "Company" or "Limoneira"

(NASDAQ: LMNR) announced today the Company's Harvest at Limoneira (formerly Santa Paula East Area 1) Project has been awarded the 2016 Comprehensive Plan Award of Excellence from the American Planning Association, California Chapter, Central Coast Section. Limoneira's plan will now move on for consideration in the APA California Chapter state awards this October in Pasadena.
LMNR: 16.62 (+0.01)

Syngenta Downgraded to Hold on Agro-Industry Headwinds
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:45PM CDT
On Apr 13, 2016, Zacks Investment Research downgraded Syngenta AG (SYT) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
SYT: 87.63 (+0.38), LMNR: 16.62 (+0.01), AU: 16.54 (+0.45), AGI: 7.29 (+0.27)

Monsanto (MON) Faces Macro Risks: Dump the Stock Now?
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 12:55PM CDT
On Apr 11, 2016, we issued an updated research report on premium agro-chemical firm Monsanto Company (MON).
MON: 107.00 (+0.50), SYT: 87.63 (+0.38), LMNR: 16.62 (+0.01), AGI: 7.29 (+0.27)

Limoneira Company Announces Formation of Limoneira South Africa
BusinessWire - Tue Apr 12, 7:30AM CDT
Limoneira Company (the "Company" or "Limoneira"

(NASDAQ: LMNR) announced today the formation of Limoneira S.A. (Limoneira South Africa) as another component of the company's One World of Citrus(R) model. Limoneira and South African based Re:inc also announced their partnership called Real Citrus to represent and manage packing and sales opportunities on the continent.
LMNR: 16.62 (+0.01)

Monsanto Misses Q2 Earnings Estimates, Cuts FY16 Guidance
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 10:02AM CDT
Monsanto Company (MON) reported disappointing results for second-quarter fiscal 2016 (ended Feb 29, 2016).
MON: 107.00 (+0.50), SYT: 87.63 (+0.38), LMNR: 16.62 (+0.01), AGI: 7.29 (+0.27)

Can Limoneira (LMNR) Run Higher on Strong Earnings Estimate Revisions?
Zacks Equity Research - Zacks Investment Research - Tue Apr 05, 7:52AM CDT
Limoneira (LMNR) has decent short-term momentum and it is seeing solid activity on the earnings estimate revision front too.
LMNR: 16.62 (+0.01)

10 Easy Tricks to Green-ify Your Life with Lemons
BusinessWire - Tue Apr 05, 7:30AM CDT
It's no secret that lemons are a boon to any kitchen or DIY beauty routine - but did you know they're a handy sustainability tool as well? With Earth Day around the corner, our Springtime focus is all about making life simpler without investing in potentially toxic chemicals or overpriced tools. We've conferred with our stellar team of opinion leaders to bring you ten great ways you can make your home life a bit more sustainable - with lemons!
LMNR: 16.62 (+0.01)

Limoneira Declares Quarterly Dividend
BusinessWire - Thu Mar 24, 7:30AM CDT
On March 21, 2016, the Board of Directors of Limoneira Company (NASDAQ: LMNR), a leading agribusiness with prime agricultural land and operations, real estate and water rights in California and Arizona, declared a quarterly cash dividend of $0.05 per common share payable on April 15, 2016, to stockholders of record on April 4, 2016.
LMNR: 16.62 (+0.01)

Limoneira Shares Down 22.4% Since SmarTrend's Sell Call (LMNR)
Comtex SmarTrend(R) - Mon Feb 08, 5:23PM CST
SmarTrend identified a Downtrend for Limoneira (NASDAQ:LMNR) on December 14th, 2015 at $15.31. In approximately 2 months, Limoneira has returned 22.40% as of today's recent price of $11.88.
LMNR: 16.62 (+0.01)

Limoneira Shares Down 17.5% Since SmarTrend's Sell Call (LMNR)
Comtex SmarTrend(R) - Mon Feb 01, 5:06PM CST
SmarTrend identified a Downtrend for Limoneira (NASDAQ:LMNR) on December 14th, 2015 at $15.31. In approximately 2 months, Limoneira has returned 17.50% as of today's recent price of $12.63.
LMNR: 16.62 (+0.01)

DIY Beauty Recipes, Tips and Tricks Using Limoneira Lemons
BusinessWire - Mon Feb 01, 7:30AM CST
Limoneira Company (Nasdaq: LMNR), one of the largest providers of lemons and avocados in the United States, has teamed up with beauty experts from around the country to showcase innovative aesthetic uses for lemons. "When life gives you lemons, take the lemons and unleash some great beauty benefits," says Megan Roosevelt, Limoneira Lemons for Life(TM) Spokesperson and CEO of Healthy Grocery Girl(R). In a new video, Megan shares a number of these tips to put your best face forward.
LMNR: 16.62 (+0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...